Article
Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.
The Journal of clinical investigation - 1 Feb 2001
Malhotra U, Holte S, Dutta S, Berrey M M, Delpit E, Koelle D M, Sette A, Corey L, McElrath M J
Abstract excerpt
HIV-1-infected patients treated early with combination antiretrovirals respond favorably, but not all maintain viral suppression and improved HIV-specific Th function. To understand if genetic factors contribute to this variation, we prospectively evaluated over 18 months 21 early-treated patients stratified by alleles of class II haplotypes. All seven subjects with the DRB1*13-DQB1*06 haplotype, but only 21% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
